Evidence map›Paper›PMID 41852931›Full record

ArticleIEEE transactions on audio, speech, and language processing (2025)2026

An End-to-End Overview of Clinical Speech AI.

Si-Ioi Ng, Lingfeng Xu, Ingo Siegert, Nicholas Cummins, Nina R Benway, Julie Liss, Visar Berisha

Abstract read
In one paragraph

Article in IEEE transactions on audio, speech, and language processing (2025), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Si-Ioi NgSi-Ioi Ng, Lingfeng Xu, Julie Liss and Visar Berisha are with Arizona State University, Tempe, AZ, USA Ingo Siegert is with Otto von Guericke University, Magdeburg, Germany, Nicholas Cummins is with King's College London, United Kingdom, Nina R. Benway is with University of Maryland, College Park, MD, USA.
Lingfeng XuSi-Ioi Ng, Lingfeng Xu, Julie Liss and Visar Berisha are with Arizona State University, Tempe, AZ, USA Ingo Siegert is with Otto von Guericke University, Magdeburg, Germany, Nicholas Cummins is with King's College London, United Kingdom, Nina R. Benway is with University of Maryland, College Park, MD, USA.
Ingo SiegertSi-Ioi Ng, Lingfeng Xu, Julie Liss and Visar Berisha are with Arizona State University, Tempe, AZ, USA Ingo Siegert is with Otto von Guericke University, Magdeburg, Germany, Nicholas Cummins is with King's College London, United Kingdom, Nina R. Benway is with University of Maryland, College Park, MD, USA.
Nicholas CumminsSi-Ioi Ng, Lingfeng Xu, Julie Liss and Visar Berisha are with Arizona State University, Tempe, AZ, USA Ingo Siegert is with Otto von Guericke University, Magdeburg, Germany, Nicholas Cummins is with King's College London, United Kingdom, Nina R. Benway is with University of Maryland, College Park, MD, USA.
Nina R BenwaySi-Ioi Ng, Lingfeng Xu, Julie Liss and Visar Berisha are with Arizona State University, Tempe, AZ, USA Ingo Siegert is with Otto von Guericke University, Magdeburg, Germany, Nicholas Cummins is with King's College London, United Kingdom, Nina R. Benway is with University of Maryland, College Park, MD, USA.
Julie LissSi-Ioi Ng, Lingfeng Xu, Julie Liss and Visar Berisha are with Arizona State University, Tempe, AZ, USA Ingo Siegert is with Otto von Guericke University, Magdeburg, Germany, Nicholas Cummins is with King's College London, United Kingdom, Nina R. Benway is with University of Maryland, College Park, MD, USA.
Visar BerishaSi-Ioi Ng, Lingfeng Xu, Julie Liss and Visar Berisha are with Arizona State University, Tempe, AZ, USA Ingo Siegert is with Otto von Guericke University, Magdeburg, Germany, Nicholas Cummins is with King's College London, United Kingdom, Nina R. Benway is with University of Maryland, College Park, MD, USA.

Funding

Perception of dysarthric speech: An objective model of dysarthric speech evaluation with actionable outcomesR01DC006859 · NIDCD · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BERISHA, VISAR, LISS, JULIE M · 2004 to 2021
$4.8M
Objectively Quantifying Speech Outcomes of Children with Cleft PalateR21DE026252 · NIDCR · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BERISHA, VISAR, SCHERER, NANCY J. · 2018 to 2019
$429k
The effects of telepractice technology on dysarthric speech evaluationR21DC019475 · NIDCD · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BERISHA, VISAR, LISS, JULIE M · 2021 to 2022
$414k
NIDCD NIH HHS R01 DC006859NIDCD NIH HHS R21 DC019475NIDCR NIH HHS R21 DE026252
6 · The paper itself

Abstract

There has been a surge of interest in the use of speech as a biomarker for a wide range of health conditions, based on the premise that neurological, mental or physical impairments affecting speech production can be objectively assessed by automated analysis. Recent advances in clinical speech artificial intelligence (AI) have applied supervised learning techniques, similar to those used in general-purpose speech technology applications, to support the diagnosis and monitoring of mental health, cognitive decline, and motor disorders. Although clinical speech AI offers significant promise as a scalable and low-burden tool for health assessment, it also presents unique challenges compared to other speech technology applications. These include the need for condition-specific speech elicitation tasks, limited and heterogeneous datasets, sensitive data collection protocols, diverse speech representation and modeling strategies, and uncertainty in ground-truth clinical labels. This overview synthesizes the emerging literature that addresses these challenges in the full clinical speech AI pipeline: from speech elicitation and recording to representation, model development, and deployment. We provide a practical review of the field, including the technical pipeline for clinical AI, the design of clinical speech tasks, data collection practices, traditional and clinically oriented speech representations, predictive modeling approaches, and ethical considerations. We also discuss open technical and translational challenges and outline future research directions. The goal is to equip researchers and algorithm developers with the knowledge needed to move clinical speech AI from experimental development to real-world clinical impact.

Indexed as

clinical speech modeldata collectionethicsmeasurement theorypathological speechSpeech AIspeech elicitation tasksspeech featuresspeech productionvalidations

Identifiers

PMID41852931
PMCPMC12994280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.